Kraken Robotics: A Deep Dive into Subsea Autonomy and Growth Prospects
Finance

Kraken Robotics: A Deep Dive into Subsea Autonomy and Growth Prospects

authorBy Suze Orman
DateJul 09, 2026
Read time2 min

Kraken Robotics has significantly bolstered its position in the subsea technology market through the strategic acquisition of Covelya Group. This pivotal move transforms Kraken into a comprehensive provider of subsea autonomous solutions, broadening its international presence and diversifying its product offerings. The integration is expected to reduce the company's dependency on U.S. defense contracts, paving the way for more balanced growth across various sectors.

The company's financial outlook appears promising, with projections for 2026 revenue ranging between CAD$290 million and CAD$310 million. Management anticipates a notable increase in earnings per share (EPS) by 2027, targeting low-to-mid double-digit accretion. This optimistic forecast is underpinned by a strong and visible order backlog, indicating sustained demand for Kraken's innovative technologies.

Despite recent market volatility that has seen Kraken's stock experience some retracement, the underlying fundamentals suggest a strong potential for recovery. A significant contributing factor to future growth is the Canadian government's substantial investment in submarine construction, a project estimated at CAD$100 billion. This initiative is expected to create significant opportunities for Kraken Robotics, driving demand for its advanced subsea systems and services.

Given these strategic developments and growth catalysts, the current market valuation appears to undervalue Kraken Robotics' long-term potential. While a further slight dip in stock price might occur, investors are advised to consider a buying opportunity, particularly if the stock price approaches the $4.05 mark. The company's enhanced capabilities, diversified market reach, and favorable industry trends position it for substantial future expansion.

Kraken Robotics' strategic maneuvers, including the Covelya Group acquisition and anticipated benefits from Canadian defense spending, are set to redefine its market standing. The company's focus on expanding its subsea autonomy offerings globally and reducing reliance on specific contracts underscores a robust and forward-looking business model. The projected revenue and EPS growth, coupled with a solid order book, suggest a compelling investment case, especially as market conditions stabilize and synergies from the acquisition fully materialize.

More Articles
Finance
Yellow Cake: Strategic Uranium Investment Amidst Favorable Market Dynamics
Yellow Cake presents a compelling investment opportunity in uranium, distinguished by its passive exposure and significant discount to Net Asset Value (NAV). The company benefits from strong supply/demand fundamentals in the uranium market, driven by persistent deficits, slow production restarts, and expanding global nuclear energy initiatives. A recent share buyback program underscores management's commitment to enhancing shareholder value, making Yellow Cake a preferable choice over traditional uranium miners for risk-adjusted returns.
By Nouriel RoubiniJul 09, 2026
Finance
Sony Ventures into Stablecoin Banking with New US Trust
Sony has obtained approval to establish a U.S. trust bank, headquartered in New York City, dedicated to supporting the issuance of dollar-backed stablecoins. This new subsidiary, fully owned by Sony Bank and capitalized with $40 million, highlights the growing global adoption of stablecoins, evidenced by a record $1.79 trillion in transaction volume this June. Sony's strategic move positions it to potentially issue its own stablecoin for its entertainment ecosystems.
By Mariana MazzucatoJul 09, 2026
Finance
The Strategic Edge: Why Active Management Excels in Small Cap Investments
In a shifting economic landscape, active management in U.S. small cap equities is gaining prominence. Structural inefficiencies within the small cap market offer fertile ground for skilled stock selectors. Adopting a diversified, multi-manager strategy can enhance portfolio robustness and unlock broader opportunities for superior returns.
By Suze OrmanJul 09, 2026
Finance
Kailera Therapeutics: A Comprehensive Strategy for the Obesity Market
Kailera Therapeutics (KLRA) is strategically positioning itself in the burgeoning obesity treatment sector, not as a mere competitor to pharmaceutical giants like Novo Nordisk or Eli Lilly, but as an innovator developing a multi-modal obesity franchise. Leveraging exclusive global rights to Hengrui Pharma's obesity drug pipeline, Kailera aims to introduce diverse treatment options. The company boasts a substantial cash reserve exceeding $1.3 billion post-IPO, ensuring financial stability for its operations until mid-2028. This robust funding is critical for advancing multiple pivotal clinical trials, including global Phase 3 trials for ribupatide and significant Phase 2/3 data for its oral GLP-1 candidates, all before needing additional capital.
By Mariana MazzucatoJul 09, 2026
Finance
Navigating Economic Expansion: AI's Impact and Market Rebalancing
The U.S. economy continues its mid-cycle expansion, driven by fiscal policies, deregulation, strong labor demand, and significant AI-fueled capital expenditures. While AI infrastructure remains a key earnings driver, contributing about 60% of S&P 500 earnings growth this quarter, the market's concentrated leadership suggests a need for a more risk-aware investment approach. We've used recent market strength to build a more diversified portfolio, poised to adapt if inflation re-accelerates or AI investment returns diminish.
By Michele FerreroJul 09, 2026